Skip to content

Elaine Schattner

writer, health care advocate, physician

  • journalist
  • about
  • academic
  • advocacy
  • ES in the News
  • speaker
  • awards
  • contact

Venetoclax Is A Powerful New Kind of Cancer Drug Effective In Chronic Lymphocytic Leukemia

cancer, conference reports, innovation, leukemia, meds, molecules, oral, targeted therapy, treatment
nci-vol-2123-150
as seen in Forbes

Venetoclax is a powerful new kind of oral medication. It enables leukemia cells to die by interfering with Bcl-2, a survival signal.

Related

apoptosisbcl-2BH3 mimeticchronic lymphocytic leukemiaCLL

More Projects

  • Five Key Issues For The Future Of Cancer IT

    Five Key Issues For The Future Of Cancer IT

  • Venetoclax Is A Powerful New Kind of Cancer Drug Effective In Chronic Lymphocytic Leukemia

    Venetoclax Is A Powerful New Kind of Cancer Drug Effective In Chronic Lymphocytic Leukemia

  • Why Prolia May Be The Better Drug For Reducing Bone Breaks And Recurrence After Breast Cancer

    Why Prolia May Be The Better Drug For Reducing Bone Breaks And Recurrence After Breast Cancer

Proudly powered by WordPress | Theme: Sketch by WordPress.com.
  • some favorites
  • being a patient
  • being a doctor
  • precision medicine
  • breast cancer
  • breast cancer screening
  • health care costs and reform
  • medical notes on TV, movies, plays, books, music…
  • public health